[Establishment of institutional GMP cell processing is mandatory for the development of novel advanced cell and gene therapy].
Maekawa
Taira
T
D064987:Cell- and Tissue-Based Therapy / Q000592:standards*; D019411:Clinical Laboratory Techniques / Q000592:standards*; D015316:Genetic Therapy / Q000592:standards*; D006801:Humans; D007564:Japan; D044968:Regenerative Medicine / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration